These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33363209)
41. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2. Sakib MMH; Nishat AA; Islam MT; Raihan Uddin MA; Iqbal MS; Bin Hossen FF; Ahmed MI; Bashir MS; Hossain T; Tohura US; Saif SI; Jui NR; Alam M; Islam MA; Hasan MM; Sufian MA; Ali MA; Islam R; Hossain MA; Halim MA Comput Biol Med; 2021 Sep; 136():104759. PubMed ID: 34403938 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from Nivetha R; Bhuvaragavan S; Muthu Kumar T; Ramanathan K; Janarthanan S J Biomol Struct Dyn; 2022; 40(21):11070-11081. PubMed ID: 34431451 [TBL] [Abstract][Full Text] [Related]
44. Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds. Khanal P; Patil VS; Bhandare VV; Dwivedi PSR; Shastry CS; Patil BM; Gurav SS; Harish DR; Roy S Comput Biol Med; 2022 Jul; 146():105668. PubMed ID: 35667894 [TBL] [Abstract][Full Text] [Related]
45. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease. Akaji K; Konno H Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349 [TBL] [Abstract][Full Text] [Related]
46. Iype E; Pillai U J; Kumar I; Gaastra-Nedea SV; Subramanian R; Saha RN; Dutta M J Biomol Struct Dyn; 2022; 40(23):12800-12811. PubMed ID: 34550861 [TBL] [Abstract][Full Text] [Related]
47. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS. Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715 [TBL] [Abstract][Full Text] [Related]
48. Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity. Wang R; Chen X; Li H; Chen X; Sun D; Yu D; Lu J; Xie Y; Zhang Q; Xu J; Zhang W; Chen H; Liu S; Chen L Int J Biol Macromol; 2024 Feb; 257(Pt 2):128623. PubMed ID: 38070810 [TBL] [Abstract][Full Text] [Related]
50. Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease. Hemmati SA; Tabein S Comput Biol Med; 2022 Mar; 142():105228. PubMed ID: 35051855 [TBL] [Abstract][Full Text] [Related]
51. Design and selection of peptides to block the SARS-CoV-2 receptor binding domain by molecular docking. Ramirez-Acosta K; Rosales-Fuerte IA; Perez-Sanchez JE; Nuñez-Rivera A; Juarez J; Cadena-Nava RD Beilstein J Nanotechnol; 2022; 13():699-711. PubMed ID: 35957673 [TBL] [Abstract][Full Text] [Related]
52. Structural Basis for the Understanding of Entry Inhibitors against SARS Viruses. Kushwaha PK; Kumari N; Nayak S; Kishor K; Sharon A Curr Med Chem; 2022; 29(4):666-681. PubMed ID: 33992054 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of SARS-CoV-2 main protease 3CL Elzupir AO J Mol Struct; 2020 Dec; 1222():128878. PubMed ID: 32834113 [TBL] [Abstract][Full Text] [Related]
54. Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E. Zhu Y; Scholle F; Kisthardt SC; Xie DY Virology; 2022 Jun; 571():21-33. PubMed ID: 35439707 [TBL] [Abstract][Full Text] [Related]
55. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease. Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340 [TBL] [Abstract][Full Text] [Related]
56. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M Hicks EG; Kandel SE; Lampe JN Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739 [TBL] [Abstract][Full Text] [Related]
57. An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2. Pennisi R; Gentile D; Rescifina A; Napoli E; Trischitta P; Piperno A; Sciortino MT Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254643 [TBL] [Abstract][Full Text] [Related]
58. Virtual Screening of Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204 [TBL] [Abstract][Full Text] [Related]
59. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Chu LH; Choy WY; Tsai SN; Rao Z; Ngai SM Protein Sci; 2006 Apr; 15(4):699-709. PubMed ID: 16600962 [TBL] [Abstract][Full Text] [Related]
60. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. Prajapat M; Shekhar N; Sarma P; Avti P; Singh S; Kaur H; Bhattacharyya A; Kumar S; Sharma S; Prakash A; Medhi B J Mol Graph Model; 2020 Dec; 101():107716. PubMed ID: 32866780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]